Breaking News Instant updates and real-time market news.

UTI

Universal Technical

$6.00 /

+0.33 (+5.82%)

16:59
04/22/20
04/22
16:59
04/22/20
16:59

Universal Technical expects to take $33M in funds through CARES Act

The company states: "More than 8,000 students from across all of UTI's campuses are currently active in the online platform, including hundreds of new students who started directly into the online curriculum over the past several weeks. UTI is currently developing plans to return students to its campuses for in-person labs as soon as it is safe and practical, following CDC and local government protocols to protect the health of students and employees. UTI expects to receive a total of approximately $33 million in funds through the CARES Act: Higher Education Relief Fund. The majority of those funds will be used to grant emergency financial aid to students impacted by COVID-19, supporting their efforts to stay in school and continue their training toward graduation and future careers. The company also will use a portion of the funds to offset costs that have arisen as a result of the COVID-19 crisis, due to the operations and infrastructure investments needed to support our students' education and curriculum needs during this time. These could include costs associated with the initial development and delivery of UTI's online educational programs as well as the transition back to on-campus, in-person lab instruction when authorities deem it safe to do so. As of March 31, 2020, UTI had no debt and its preliminary estimate of available liquidity was approximately $118 million comprised of approximately $77.6 million of cash and cash equivalents and approximately $41.5 million of short term, held to maturity securities. The estimated available liquidity includes the benefit of the $49.5 million of net proceeds the company raised in February 2020 through a primary equity offering."

UTI Universal Technical
$6.00 /

+0.33 (+5.82%)

04/02/20
Universal Technical initiated with a Buy at Dougherty
03/18/20 Lake Street
Universal Technical shares more than discount COVID-19 risks, says Lake Street
03/11/20
Fly Intel: Top five analyst initiations
03/11/20 Lake Street
Universal Technical initiated with a Buy at Lake Street

TODAY'S FREE FLY STORIES

Recommendations
Tapestry price target raised to $45 from $36 at BMO Capital » 08:16
03/05/21
03/05
08:16
03/05/21
08:16
TPR

Tapestry

$40.75 /

-0.81 (-1.95%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPR Tapestry
$40.75 /

-0.81 (-1.95%)

TPR Tapestry
$40.75 /

-0.81 (-1.95%)

02/22/21 Credit Suisse
Tapestry upgraded to Outperform with $50 target at Credit Suisse
02/22/21 Credit Suisse
Tapestry upgraded to Outperform from Neutral at Credit Suisse
02/16/21 Piper Sandler
Tapestry price target raised to $45 from $42 at Piper Sandler
02/09/21 Telsey Advisory
Tapestry upgraded to Outperform from Market Perform at Telsey Advisory
TPR Tapestry
$40.75 /

-0.81 (-1.95%)

TPR Tapestry
$40.75 /

-0.81 (-1.95%)

TPR Tapestry
$40.75 /

-0.81 (-1.95%)

Hot Stocks
ChannelAdvisor to join Google Partners International Growth program » 08:15
03/05/21
03/05
08:15
03/05/21
08:15
ECOM

ChannelAdvisor

$21.38 /

-1.68 (-7.29%)

, GOOG

Alphabet

$2,049.59 /

+23.6 (+1.16%)

, GOOGL

Alphabet Class A

$2,034.31 /

+24.26 (+1.21%)

ChannelAdvisor (ECOM) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$21.38 /

-1.68 (-7.29%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

ECOM ChannelAdvisor
$21.38 /

-1.68 (-7.29%)

02/12/21 B. Riley Securities
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley Securities
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

03/03/21 Jefferies
Google Cloud traction under Kurian 'under-appreciated,' says Jefferies
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/12/21 Citi
Citi boosts Alphabet target but shares no longer a top pick
02/08/21 Stephens
Global Payments merchant business advanced by Google pact, says Stephens
GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

03/03/21 Jefferies
Google Cloud traction under Kurian 'under-appreciated,' says Jefferies
02/17/21 Maxim
Kaleyra price target raised to $30 from $22 at Maxim
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/16/21 Loop Capital
Alphabet upgraded to Buy from Hold at Loop Capital
ECOM ChannelAdvisor
$21.38 /

-1.68 (-7.29%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

GOOG Alphabet
$2,049.59 /

+23.6 (+1.16%)

GOOGL Alphabet Class A
$2,034.31 /

+24.26 (+1.21%)

General news
Employment Situation Nonfarm Payrolls to be reported at 08:30 » 08:15
03/05/21
03/05
08:15
03/05/21
08:15

February Employment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Employment Situation Unemployment Rate to be reported at 08:30 » 08:15
03/05/21
03/05
08:15
03/05/21
08:15

February Employment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
International Trade in Goods and Services Balance to be reported at 08:30 » 08:15
03/05/21
03/05
08:15
03/05/21
08:15

January International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Turtle Beach reports Q4 adjusted EPS 84c, consensus 78c » 08:14
03/05/21
03/05
08:14
03/05/21
08:14
HEAR

Turtle Beach

$28.46 /

-0.79 (-2.70%)

Last night reported Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
02/11/21 Lake Street
Turtle Beach price target raised to $40 from $30 at Lake Street
HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

HEAR Turtle Beach
$28.46 /

-0.79 (-2.70%)

Hot Stocks
Seagen recommends shareholders reject TRC Capital mini-tender offer » 08:13
03/05/21
03/05
08:13
03/05/21
08:13
SGEN

Seagen

$145.18 /

-2.72 (-1.84%)

Seagen announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seagen
$145.18 /

-2.72 (-1.84%)

SGEN Seagen
$145.18 /

-2.72 (-1.84%)

02/16/21 RBC Capital
Seagen price target lowered to $169 from $186 at RBC Capital
02/12/21 Barclays
Seagen price target lowered to $168 from $177 at Barclays
02/12/21 Piper Sandler
Seagen price target lowered to $170 from $175 at Piper Sandler
02/01/21 RBC Capital
Seagen downgraded to Sector Perform at RBC Capital on valuation
SGEN Seagen
$145.18 /

-2.72 (-1.84%)

SGEN Seagen
$145.18 /

-2.72 (-1.84%)

Earnings
Hurco Companies reports Q1 EPS 10c vs. (13c) last year » 08:12
03/05/21
03/05
08:12
03/05/21
08:12
HURC

Hurco Companies

$30.85 /

-0.95 (-2.99%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HURC Hurco Companies
$30.85 /

-0.95 (-2.99%)

Recommendations
Jamf Holding price target raised to $49 from $45 at RBC Capital » 08:12
03/05/21
03/05
08:12
03/05/21
08:12
JAMF

Jamf Holding

$36.45 /

-1.33 (-3.52%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

06:39 Today Mizuho
Jamf Holding price target raised to $45 from $43 at Mizuho
01/28/21 Piper Sandler
Jamf Holding remains a top idea for 2021 at Piper Sandler
01/05/21 Canaccord
Jamf Holding metrics 'bode well' for strong Q4, says Canaccord
09/02/20 Canaccord
Jamf Holding upside likely in Q3, says Canaccord
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

  • 19
    Nov
  • 22
    Jul
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

Recommendations
Market undervaluing Durect's alcoholic hepatitis opportunity, says Chardan » 08:12
03/05/21
03/05
08:12
03/05/21
08:12
DRRX

Durect

$2.05 /

-0.13 (-5.96%)

Chardan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.05 /

-0.13 (-5.96%)

DRRX Durect
$2.05 /

-0.13 (-5.96%)

02/03/21 Jefferies
Posimir should not be significant threat to Pacira's Exparel, says Jefferies
02/03/21 Chardan
Chardan boosts Durect target to $8 with 'final overhang' removed
02/02/21 Oppenheimer
Posimir approval a 'significant positive' for Durect, says Oppenheimer
02/02/21 Roth Capital
Roth reiterates $7 target on Durect after 'surprise' FDA approval
DRRX Durect
$2.05 /

-0.13 (-5.96%)

  • 04
    Feb
DRRX Durect
$2.05 /

-0.13 (-5.96%)

Hot Stocks
Virgin Galactic down 7% after Palihapitiya sells 6.2M shares » 08:11
03/05/21
03/05
08:11
03/05/21
08:11
SPCE

Virgin Galactic

$30.29 /

-1.72 (-5.37%)

Chamath Palihapitiya,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

03/03/21 BofA
Virgin Galactic price target raised to $50 from $35 at BofA
02/26/21 Alembic Global
Virgin Galactic downgraded to Neutral from Overweight at Alembic Global
02/26/21 UBS
Virgin Galactic price target lowered to $40 from $52 at UBS
02/09/21 UBS
Virgin Galactic downgraded to Neutral from Buy at UBS
SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

  • 06
    Aug
  • 03
    Jun
  • 20
    May
SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

SPCE Virgin Galactic
$30.29 /

-1.72 (-5.37%)

Hot Stocks
Huntington Ingalls appoints Kari Wilkinson as president, Shipbuilding division » 08:11
03/05/21
03/05
08:11
03/05/21
08:11
HII

Huntington Ingalls

$179.32 /

-3.55 (-1.94%)

Huntington Ingalls…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

01/06/21 Vertical Research
Huntington Ingalls downgraded to Hold from Buy at Vertical Research
12/04/20 Alembic Global
Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global
10/02/20 JPMorgan
Huntington Ingalls price target lowered to $175 from $205 at JPMorgan
10/01/20 Barclays
Huntington Ingalls price target lowered to $160 from $190 at Barclays
HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

HII Huntington Ingalls
$179.32 /

-3.55 (-1.94%)

Hot Stocks
Hanesbrands appoints Tracy Preston general counsel, chief compliance officer » 08:11
03/05/21
03/05
08:11
03/05/21
08:11
HBI

Hanesbrands

$18.44 /

-0.35 (-1.86%)

HanesBrands announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

02/10/21 B. Riley Securities
Hanesbrands price target raised to $22 from $19 at B. Riley Securities
02/10/21 Barclays
Hanesbrands price target raised to $26 from $16 at Barclays
01/21/21 Deutsche Bank
Hanesbrands price target raised to $16 from $14 at Deutsche Bank
12/14/20
Fly Intel: Top five analyst downgrades
HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

HBI Hanesbrands
$18.44 /

-0.35 (-1.86%)

Recommendations
Purple Innovation price target lowered to $32 from $38 at Wedbush » 08:09
03/05/21
03/05
08:09
03/05/21
08:09
PRPL

Purple Innovation

$24.42 /

-11.76 (-32.50%)

Wedbush analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

08:05 Today Raymond James
Purple Innovation price target lowered to $32 from $36 at Raymond James
06:21 Today UBS
Purple Innovation price target lowered to $32 from $44 at UBS
01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
01/12/21 Wedbush
Purple Innovation price target raised to $38 from $32 at Wedbush
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

PRPL Purple Innovation
$24.42 /

-11.76 (-32.50%)

Hot Stocks
Second Sight receives FDA approval for Argus 2s Retinal Prosthesis System » 08:09
03/05/21
03/05
08:09
03/05/21
08:09
EYES

Second Sight

$1.43 /

-0.29 (-16.86%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYES Second Sight
$1.43 /

-0.29 (-16.86%)

EYES Second Sight
$1.43 /

-0.29 (-16.86%)

04/01/20 H.C. Wainwright
Second Sight rating placed under review at H.C. Wainwright
  • 01
    May
Hot Stocks
Brickell Biotech to host KOL webinar on the hyperhidrosis market » 08:08
03/05/21
03/05
08:08
03/05/21
08:08
BBI

Brickell Biotech

$1.17 /

+ (+0.00%)

Brickell Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBI Brickell Biotech
$1.17 /

+ (+0.00%)

BBI Brickell Biotech
$1.17 /

+ (+0.00%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
  • 23
    Oct
  • 18
    Jun
Hot Stocks
Fathom acquires real estate brokerage business of Red Barn Real Estate » 08:08
03/05/21
03/05
08:08
03/05/21
08:08
FTHM

Fathom

$34.78 /

-5.22 (-13.05%)

Fathom Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTHM Fathom
$34.78 /

-5.22 (-13.05%)

FTHM Fathom
$34.78 /

-5.22 (-13.05%)

02/10/21 Roth Capital
Roth raises Fathom target to $52, sees 'multifold benefits' from Naberly deal
02/09/21 DA Davidson
Fathom initiated with a Buy at DA Davidson
01/25/21 Roth Capital
Fathom price target raised to $50 from $40 at Roth Capital
12/28/20 Roth Capital
Fathom price target raised to $40 from $28 at Roth Capital
  • 28
    Jul
Hot Stocks
Immutep expands Part B of TACTI-002 Phase II study » 08:07
03/05/21
03/05
08:07
03/05/21
08:07
IMMP

Immutep

$2.41 /

-0.2 (-7.66%)

Immutep is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMMP Immutep
$2.41 /

-0.2 (-7.66%)

IMMP Immutep
$2.41 /

-0.2 (-7.66%)

01/26/21 Alliance Global Partners
Immutep price target raised to $6 from $5 at Alliance Global Partners
12/14/20 Maxim
Maxim doubled Immutep price target after breast cancer update
11/11/20 Maxim
Immutep price target raised to $4 from $2 at Maxim
09/22/20
Top five analyst initiations
IMMP Immutep
$2.41 /

-0.2 (-7.66%)

Recommendations
Joint Corp. price target raised to $54 from $28 at Maxim » 08:07
03/05/21
03/05
08:07
03/05/21
08:07
JYNT

Joint Corp.

$44.28 /

-4.77 (-9.72%)

Maxim analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JYNT Joint Corp.
$44.28 /

-4.77 (-9.72%)

JYNT Joint Corp.
$44.28 /

-4.77 (-9.72%)

02/25/21 B. Riley Securities
Joint Corp. price target raised to $47 from $26 at B. Riley Securities
01/06/21 Craig-Hallum
Joint Corp. price target raised to $38 from $26 at Craig-Hallum
01/04/21 Lake Street
Joint Corp. price target raised to $35 from $25 at Lake Street
11/06/20 B. Riley Securities
Joint Corp. price target raised to $26 from $22 at B. Riley Securities
JYNT Joint Corp.
$44.28 /

-4.77 (-9.72%)

Hot Stocks
Allied Esports confirms proposal from Bally's to acquire the company for $100M » 08:07
03/05/21
03/05
08:07
03/05/21
08:07
AESE

Allied Esports Entertainment

$3.27 /

+0.77 (+30.80%)

, BALY

Bally's

$52.30 /

-8.27 (-13.65%)

Allied Esports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AESE Allied Esports Entertainment
$3.27 /

+0.77 (+30.80%)

BALY Bally's
$52.30 /

-8.27 (-13.65%)

AESE Allied Esports Entertainment
$3.27 /

+0.77 (+30.80%)

06/08/20 Alliance Global Partners
Alliance Global says Allied Esports refinancing eliminates near-term overhang
05/15/20 Stephens
Allied Esports Entertainment price target lowered to $4 from $5 at Stephens
05/06/20 Alliance Global Partners
Allied Esports Entertainment initiated with a Buy at Alliance Global Partners
BALY Bally's
$52.30 /

-8.27 (-13.65%)

06:55 Today Stifel
Stifel upgrades Bally's to Buy after 'overplayed' post-earnings dip
05:30 Today Stifel
Bally's upgraded to Buy from Hold at Stifel
02/24/21 Truist
Bally's price target raised to $80 from $65 at Truist
02/09/21 Stifel
Bally's price target raised to $60 from $50 at Stifel
BALY Bally's
$52.30 /

-8.27 (-13.65%)

BALY Bally's
$52.30 /

-8.27 (-13.65%)

AESE Allied Esports Entertainment
$3.27 /

+0.77 (+30.80%)

BALY Bally's
$52.30 /

-8.27 (-13.65%)

Recommendations
Outfront Media price target raised to $24 from $22 at Barrington » 08:07
03/05/21
03/05
08:07
03/05/21
08:07
OUT

Outfront Media

$21.47 /

-0.305 (-1.40%)

Barrington analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OUT Outfront Media
$21.47 /

-0.305 (-1.40%)

03/02/21 Citi
Outfront Media price target raised to $25 from $21 at Citi
11/12/20 Citi
Outfront Media price target raised to $21 from $18 at Citi
11/02/20 Morgan Stanley
Lamar Advertising upgraded at Morgan Stanley with recovery not priced in
09/25/20 Citi
Outfront Media upgraded to Buy from Neutral at Citi
OUT Outfront Media
$21.47 /

-0.305 (-1.40%)

  • 23
    Feb
OUT Outfront Media
$21.47 /

-0.305 (-1.40%)

Hot Stocks
Keros presents results from preclinical studies of KER-050, ALK2 Inhibitors » 08:06
03/05/21
03/05
08:06
03/05/21
08:06
KROS

Keros Therapeutics

$55.16 /

-2.32 (-4.04%)

Keros Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$55.16 /

-2.32 (-4.04%)

KROS Keros Therapeutics
$55.16 /

-2.32 (-4.04%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
  • 13
    Nov
  • 08
    Apr
KROS Keros Therapeutics
$55.16 /

-2.32 (-4.04%)

Recommendations
Cooper Companies price target raised to $415 from $375 at Raymond James » 08:06
03/05/21
03/05
08:06
03/05/21
08:06
COO

Cooper Companies

$371.84 /

-9.125 (-2.40%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

06:52 Today Baird
Cooper Companies price target raised to $384 from $351 at Baird
06:19 Today Citi
Cooper Companies price target raised to $378 from $355 at Citi
02/11/21 Piper Sandler
Cooper Companies price target raised to $435 from $370 at Piper Sandler
01/25/21 Wells Fargo
Cooper Companies price target raised to $445 from $415 at Wells Fargo
COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

Hot Stocks
PriceSmart announces February net merchandise sales up 1.3% to $258.7M » 08:06
03/05/21
03/05
08:06
03/05/21
08:06
PSMT

PriceSmart

$91.39 /

-3.43 (-3.62%)

PriceSmart announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSMT PriceSmart
$91.39 /

-3.43 (-3.62%)

PSMT PriceSmart
$91.39 /

-3.43 (-3.62%)

05/08/20 Scotiabank
Scotiabank downgrades PriceSmart amid COVID-19 restrictions
05/08/20 Scotiabank
PriceSmart downgraded to Sector Perform from Outperform at Scotiabank
PSMT PriceSmart
$91.39 /

-3.43 (-3.62%)

PSMT PriceSmart
$91.39 /

-3.43 (-3.62%)

Recommendations
NGM Biopharmaceuticals price target raised to $44 from $39 at Chardan » 08:06
03/05/21
03/05
08:06
03/05/21
08:06
NGM

NGM Biopharmaceuticals

$27.10 /

-1.36 (-4.78%)

Chardan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGM NGM Biopharmaceuticals
$27.10 /

-1.36 (-4.78%)

NGM NGM Biopharmaceuticals
$27.10 /

-1.36 (-4.78%)

02/09/21 Goldman Sachs
NGM Biopharmaceuticals price target raised to $38 from $28 at Goldman Sachs
01/08/21 Raymond James
NGM Biopharmaceuticals price target raised to $50 from $32 at Raymond James
01/05/21 Stifel
NGM Biopharmaceuticals named a top pick, price target boosted to $43 at Stifel
12/21/20 Citi
NGM Biopharmaceuticals price target raised to $44 from $28 at Citi
NGM NGM Biopharmaceuticals
$27.10 /

-1.36 (-4.78%)

  • 06
    Jan
NGM NGM Biopharmaceuticals
$27.10 /

-1.36 (-4.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.